NANO-X IMAGING Shares Spike To The Upside; Traders Circulate Analyst Comments Saying "Nanox Is Integrating AI Into Its Imaging Platform To Enhance The Accuracy And Speed Of Diagnoses. Approval Of It's Pending FDA 510(k) Submission Indication Would...
NANO-X IMAGING Shares Spike To The Upside; Traders Circulate Analyst Comments Saying "Nanox Is Integrating AI Into Its Imaging Platform To Enhance The Accuracy And Speed Of Diagnoses. Approval Of It's Pending FDA 510(k) Submission Indication Would...
NANO-X IMAGING股價飆升；交易員傳遞分析師評論稱"Nanox正在將人工智能集成到其影像平台中，以提高診斷的準確性和速度。批准其待定的FDA 510(k)提交指示將...
NANO-X IMAGING Shares Spike To The Upside; Traders Circulate Analyst Comments Saying "Nanox Is Integrating AI Into Its Imaging Platform To Enhance The Accuracy And Speed Of Diagnoses. Approval Of It's Pending FDA 510(k) Submission Indication Would Also Allow The Co To Address A Broader Set Of Clinical Needs, Improving The Utilization Of Its Installed Systems"
NANO-X IMAGING股價上漲；交易員流傳相關分析師的評論稱"Nanox正在將人工智能整合到其成像平台中，以提高診斷的準確性和速度。待批准的FDA 510(k)遞交指標還將使公司能夠應對更廣泛的臨床需求，提高其安裝系統的利用率"
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。